Predict your next investment

HEALTHCARE | Drug Delivery
orieltherapeutics.com

See what CB Insights has to offer

Founded Year

2001

Stage

Acquired | Acquired

Total Raised

$11.5M

About Oriel Therapeutics

Oriel Therapeutics is a respiratory drug delivery company developing dry powder delivery systems for the treatment of asthma and COPD.On April 19, 2010, Oriel Therapeutics was acquired by Sandox. The terms of the transaction were not disclosed.

Oriel Therapeutics Headquarter Location

630 Davis Drive Suite 120

Durham, North Carolina, 27713,

United States

919-313-1290

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Oriel Therapeutics Patents

Oriel Therapeutics has filed 32 patents.

The 3 most popular patent topics include:

  • Dosage forms
  • Drug delivery devices
  • Medical equipment
patents chart

Application Date

Grant Date

Title

Related Topics

Status

2/6/2017

12/3/2019

Dosage forms, Drug delivery devices, Routes of administration, Medical equipment, Medical treatments

Grant

Application Date

2/6/2017

Grant Date

12/3/2019

Title

Related Topics

Dosage forms, Drug delivery devices, Routes of administration, Medical equipment, Medical treatments

Status

Grant

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.